Teva Pharmaceuticals USA recalls DAUNOrubicin Hydrochloride Injection 20 mg/4mL, 4mL Single Dose vials, 10 in 1 carton, Rx only, Teva Parenteral Medicine
Recalled August 25, 2021 · FDA recall D-0730-2021 · Teva Pharmaceuticals USA
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
1,351 vials
Sold at
Product was distributed Nationwide, including Puerto Rico.
Description
Lack of Assurance of Sterility
Product
DAUNOrubicin Hydrochloride Injection 20 mg/4mL, 4mL Single Dose vials, 10 in 1 carton, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618 Vial NDC# 0703-5233-11, Carton NDC # 0703-5233-13
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →